Gapping up
In reaction to strong earnings/guidance:
- NEPT +13.8%
M&A news:
- P +7.8% (Sirius XM (SIRI) might be interested in acquiring Pandora, according to NY Post, also expects to exceed Q4 guidance)
- SN +7.8% (Anadarko Petroleum to sell Eagleford Shale assets in South Texas for approx $2.3 bln to Sanchez Energy and Blackstone Group),
Other news:
- RXII +40.4% (OPKO Health (OPK) increases stake to 5.11% (Prior 3.43%), changes shareholding position to passive from active)
- TBIO +27.7% (continued momentum)
- TTNP +22% ( CMC has granted a opermanent J-code for Probuphine)
- IOTS +5.3% (after ~50% move higher on Thursday)
- OPXA +5.2% (following late move higher into the close)
- OREX +4.4% (after spiking higher into the close)
- NVLS +4.1% (approved a restructuring plan as part of the Company's initiative to explore strategic alternatives; cutting 25 of 30 emplyees, including the CEO and CMO)
- IMMU +3.8% (continued momentum)
- ZIOP +3.6% ( following Najarian mention on CNBC)
Analyst comments:
- MBLY +2.8% (initiated with a Buy at Jefferies)
- GRUB +2.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- CNHI +2% (upgraded to Neutral from Underperform at BofA/Merrill )
- NOK +1.5% (upgraded to Buy from Neutral at Natixis)
- NFLX +1.2% (upgraded to Hold at Deutsche Bank)
- CIEN +0.7% (initiated with a Buy at UBS)
- FB +0.7% (upgraded to Strong Buy from Outperform at Raymond James)